OBJECTIVE: Topiramate (TPM) is a new antiepileptic drug, which has a wide spectrum of
activities suggesting a potentially valuable therapeutic profile. Our objective is to report our …

Topiramate is an antiepileptic drug (AED) which appears to have a broad range of
antiseizure activity in humans. A previous overview focused primarily on results of trials of …

At a tertial referral epilepsy centre 39 children were consecutively enrolled in an open add-
on study with topiramate (TPM). All children had intractable epilepsy; the mean seizure …

OBJECTIVE: To evaluate the long-term efficacy, safety, and retention rate of topiramate
(TPM) in childhood refractory epilepsies. METHODS: This study was designed as a single …

A 3-year retrospective review was undertaken of the use of topiramate in 51 children aged 3–
16 years with partial and generalized epilepsies who attended a tertiary referral epilepsy …

Many studies showed that Topiramate (TPM) may be a useful drug in a wide spectrum of
childhood epilepsies. We report a 3-month-old female with stormy onset of secondarily …

Objectives: To study the effectiveness and safety of topiramate in clinical practice, for a
group of patients with childhood onset epilepsy. Methods: All patients treated with …

To evaluate the efficacy of topiramate (TPM) for the treatment of children with epilepsies, we
introduced TPM to 45 patients whose epilepsy began in childhood and whose ages ranged …

This study aimed to evaluate the long-term efficacy and safety of topiramate in treating
children with drug-resistant epilepsy. A multicentric, retrospective, open-label, add-on study …

OBJECTIVES:: This study has been conducted to assess the efficacy and safety of
topiramate in refractory epilepsies in infants and young children. METHODS:: A prospective …